BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 21573488)

  • 21. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells.
    Solchaga LA; Penick K; Porter JD; Goldberg VM; Caplan AI; Welter JF
    J Cell Physiol; 2005 May; 203(2):398-409. PubMed ID: 15521064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal mesenchymal stem cells derived from human bone marrow can differentiate into hepatocyte-like cells in injured livers of SCID mice.
    Tao XR; Li WL; Su J; Jin CX; Wang XM; Li JX; Hu JK; Xiang ZH; Lau JT; Hu YP
    J Cell Biochem; 2009 Oct; 108(3):693-704. PubMed ID: 19693776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inducible immortality in hTERT-human mesenchymal stem cells.
    Piper SL; Wang M; Yamamoto A; Malek F; Luu A; Kuo AC; Kim HT
    J Orthop Res; 2012 Dec; 30(12):1879-85. PubMed ID: 22674533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering.
    Pytlík R; Stehlík D; Soukup T; Kalbácová M; Rypácek F; Trc T; Mulinková K; Michnová P; Kideryová L; Zivný J; Klener P; Veselá R; Trnený M; Klener P
    Biomaterials; 2009 Jul; 30(20):3415-27. PubMed ID: 19362364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
    Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
    Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of p21(Cip1/Waf1) enhances proliferation, the expression of stemness markers, and osteogenic potential in human mesenchymal stem cells.
    Yew TL; Chiu FY; Tsai CC; Chen HL; Lee WP; Chen YJ; Chang MC; Hung SC
    Aging Cell; 2011 Apr; 10(2):349-61. PubMed ID: 21342417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardin a enhances telomerase activities in adipose tissue mesenchymal cells and embryonic stem cells undergoing cardiovascular myogenic differentiation.
    Madonna R; Willerson JT; Geng YJ
    Stem Cells; 2008 Jan; 26(1):202-11. PubMed ID: 17916802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability.
    Shahdadfar A; Frønsdal K; Haug T; Reinholt FP; Brinchmann JE
    Stem Cells; 2005 Oct; 23(9):1357-66. PubMed ID: 16081661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The lamina propria of adult human oral mucosa harbors a novel stem cell population.
    Marynka-Kalmani K; Treves S; Yafee M; Rachima H; Gafni Y; Cohen MA; Pitaru S
    Stem Cells; 2010 May; 28(5):984-95. PubMed ID: 20474080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parameters in three-dimensional osteospheroids of telomerized human mesenchymal (stromal) stem cells grown on osteoconductive scaffolds that predict in vivo bone-forming potential.
    Burns JS; Rasmussen PL; Larsen KH; Schrøder HD; Kassem M
    Tissue Eng Part A; 2010 Jul; 16(7):2331-42. PubMed ID: 20196644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells.
    Zaim M; Karaman S; Cetin G; Isik S
    Ann Hematol; 2012 Aug; 91(8):1175-86. PubMed ID: 22395436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro transformation of mesenchymal stem cells by oncogenic H-rasVal12.
    Shima Y; Okamoto T; Aoyama T; Yasura K; Ishibe T; Nishijo K; Shibata KR; Kohno Y; Fukiage K; Otsuka S; Uejima D; Nakayama T; Nakamura T; Kiyono T; Toguchida J
    Biochem Biophys Res Commun; 2007 Feb; 353(1):60-6. PubMed ID: 17173860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granulocyte-macrophage colony-stimulating factor and interleukin 4 induce the malignant transformation of the bone marrow-derived human adult mesenchymal stem cells.
    Zhou XG; Yang Y; Yang JS; Zhou J; Fang TL; Dai WD; Chen ZR
    Chin Med J (Engl); 2011 Mar; 124(5):729-33. PubMed ID: 21518567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophagic response to human mesenchymal stem cell and poly(epsilon-caprolactone) implantation in nonobese diabetic/severe combined immunodeficient mice.
    Xia Z; Ye H; Choong C; Ferguson DJ; Platt N; Cui Z; Triffitt JT
    J Biomed Mater Res A; 2004 Dec; 71(3):538-48. PubMed ID: 15481051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage.
    François S; Bensidhoum M; Mouiseddine M; Mazurier C; Allenet B; Semont A; Frick J; Saché A; Bouchet S; Thierry D; Gourmelon P; Gorin NC; Chapel A
    Stem Cells; 2006 Apr; 24(4):1020-9. PubMed ID: 16339642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neural tumor-initiating cells have distinct telomere maintenance and can be safely targeted for telomerase inhibition.
    Castelo-Branco P; Zhang C; Lipman T; Fujitani M; Hansford L; Clarke I; Harley CB; Tressler R; Malkin D; Walker E; Kaplan DR; Dirks P; Tabori U
    Clin Cancer Res; 2011 Jan; 17(1):111-21. PubMed ID: 21208905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase activity and expression in adult human mesenchymal stem cells derived from amyotrophic lateral sclerosis individuals.
    Tichon A; Gowda BK; Slavin S; Gazit A; Priel E
    Cytotherapy; 2009; 11(7):837-48. PubMed ID: 19903097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation.
    Sun B; Chen M; Hawks CL; Hornsby PJ
    Cancer Res; 2005 Aug; 65(15):6512-5. PubMed ID: 16061628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model.
    Qiao L; Xu Z; Zhao T; Zhao Z; Shi M; Zhao RC; Ye L; Zhang X
    Cell Res; 2008 Apr; 18(4):500-7. PubMed ID: 18364678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexamethasone treatment during the expansion phase maintains stemness of bone marrow mesenchymal stem cells.
    Xiao Y; Peperzak V; van Rijn L; Borst J; de Bruijn JD
    J Tissue Eng Regen Med; 2010 Jul; 4(5):374-86. PubMed ID: 20058244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.